Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Exercise therapy aims to boost recovery in Bone-Weakened myeloma patients

NCT ID NCT07388147

First seen Feb 04, 2026 · Last updated Jun 24, 2026 · Updated 15 times

Summary

This study tests whether orthopedic check-ups and custom exercise plans can improve physical function and rehabilitation in people with multiple myeloma who have bone lesions. About 71 newly diagnosed patients will receive ongoing bone stability assessments and tailored exercise advice during their cancer treatment. The goal is to create a safe, routine program that helps patients stay active and recover better.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA BONE LESIONS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Heidelberg University Hospital - GMMG Study Group

    Heidelberg, 69120, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

exercise therapy

What this could lead to

If successful, this could provide a safe, structured exercise program to help multiple myeloma patients improve physical function and quality of life during treatment.

What could go wrong

This is a small, early-stage study (71 participants) focused on feasibility, not a large trial. Results may not apply to all patients, and exercise risks for those with bone lesions need careful monitoring.

Conditions

The condition(s) this trial relates to.

plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.